French authorities raid drug company offices to investigate collusion over eye drugBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g2815 (Published 15 April 2014) Cite this as: BMJ 2014;348:g2815
- Nigel Hawkes
Competition authorities in France have raided the offices of Roche and Novartis and confiscated material in connection with an investigation into alleged collusion over treatment for age related macular degeneration (AMD).
The raids are the latest stage in an investigation begun in 2012 at the prompting of the health minister, Marisol Touraine. Novartis markets ranibizumab (Lucentis) in Europe for the treatment of wet AMD, while Roche sells the related cancer drug, bevacizumab (Avastin). The complaint being investigated is that the two companies colluded to prevent the use of the much cheaper Avastin to treat the eye condition. …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial